The United States has achieved a historic milestone in cancer treatment, with seven out of ten people now surviving cancer for at least five years. This represents a significant improvement from previous decades, reflecting advancements in prevention, detection, and treatment innovations. The 70% five-year survival rate is a result of decades of scientific investment which has transformed many cancers from being deadly to manageable chronic conditions.

The progress in cancer survival rates can be attributed to breakthroughs in treatment, such as immunotherapy and targeted therapies, that have emerged in recent years. These treatments have led to improvements in survival rates for cancers that were previously considered deadly. Despite these advancements, there are still significant disparities in cancer outcomes based on race, ethnicity, and socioeconomic status. Addressing these disparities and ensuring equal access to high-quality cancer care will be essential in ensuring that all Americans benefit equally from advances in cancer treatment.